drugset / Trial / NCT03673124
Ribociclib and Letrozole Treatment in Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or peritoneum.
Timeline
- Start
- 2019-05-20
- Primary completion
- 2024-12-23
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |
| Subject | Ribociclib | Small molecule | 600 mg | Oral |